Pasquale Longobardi

This version is not peer-reviewed. Enrico Moccia  * ,Pasquale Longobardi ,Vincenzo Lionetti ,Marco Scalese Enrico Moccia  * ,Pasquale Longobardi ,Vincenzo Lionetti ,Marco Scalese You are already at the latest version female infertility ; hyperbaric oxygen therapy ; HBOT ; sirtuins ; SIRT1 This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Yuyao Zhang1, Yijun Zhou1, Yuanyuan Jia1, Tiantian Wang1 and Dianhuai Meng2* 1School of Rehabilitation Medicine, Nanjing Medical University, Nanjing, Jiangsu, China 2First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China Introduction: Hyperbaric oxygen therapy (HBOT) is one of the common clinical treatments, but adverse effects have hampered and limited the clinical application and promotion of hyperbaric oxygen therapy.